Provided by Tiger Trade Technology Pte. Ltd.

ADMA Biologics

15.57
+0.39002.57%
Post-market: 15.28-0.2900-1.86%19:45 EST
Volume:4.47M
Turnover:68.27M
Market Cap:3.71B
PE:25.95
High:15.63
Open:14.90
Low:14.55
Close:15.18
52wk High:25.67
52wk Low:13.50
Shares:238.00M
Float Shares:233.86M
Volume Ratio:1.14
T/O Rate:1.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):0.6000
ROE:35.56%
ROA:21.50%
PB:7.76
PE(LYR):25.95

Loading ...

ADMA Biologics CEO Adam S. Grossman Reports Disposal of Common Shares

Reuters
·
Dec 17, 2025

ADMA Biologics (ADMA): Assessing Valuation as Short Interest Declines and Market Sentiment Improves

Simply Wall St.
·
Nov 27, 2025

High Growth Tech Stocks In The US For November 2025

Simply Wall St.
·
Nov 24, 2025

ADMA Biologics CEO Adam S. Grossman Reports Disposal of Common Shares

Reuters
·
Nov 22, 2025

ADMA Biologics (ADMA) Receives a New Rating from Cantor Fitzgerald

TIPRANKS
·
Nov 06, 2025

ADMA Biologics Reports Strong Q3 2025 Financial Results

TIPRANKS
·
Nov 06, 2025

Stock Track | ADMA Biologics Plunges 5.72% After-Hours Despite Strong Q3 Results and Raised Guidance

Stock Track
·
Nov 06, 2025

BRIEF-ADMA Biologics Q3 Revenue USD 134.2 Million

Reuters
·
Nov 06, 2025

ADMA Biologics Inc Outlook 2026 Total Revenue: Raised to at Least $630 Million

THOMSON REUTERS
·
Nov 06, 2025

ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Nov 06, 2025

Adma Biologics options imply 14.3% move in share price post-earnings

TIPRANKS
·
Nov 06, 2025

Stock Track | ADMA Biologics Soars 5% Ahead of Expected Strong Q3 Earnings Report

Stock Track
·
Nov 06, 2025

Stock Track | ADMA Biologics Soars 5.06% Ahead of Expected Positive Q3 Earnings

Stock Track
·
Nov 06, 2025

ADMA Biologics Inc expected to post earnings of 15 cents a share - Earnings Preview

Reuters
·
Nov 04, 2025

ADMA Biologics Inc. to Report Third Quarter 2025 Financial Results

Reuters
·
Oct 29, 2025

ADMA Biologics CEO Adam S. Grossman Reports Sale of Common Shares

Reuters
·
Oct 25, 2025

Assessing ADMA Biologics’s Valuation Following Bold Multi-Year Growth Targets and Manufacturing Upgrades

Simply Wall St.
·
Oct 16, 2025

Exploring High Growth Tech Stocks in the US Market

Simply Wall St.
·
Sep 26, 2025